
Longevity Club
A mobile and web membership platform combining concierge access, a health and wellbeing marketplace, member education and loyalty rewards.
Explore Longevity Club →Deep Knowledge Group invests in publicly traded companies, private technology businesses and the Group’s own commercial platforms. Since its first longevity investment in 2014, DKG has combined capital with scientific intelligence, technology development and the acquisition of intellectual property and knowledge assets.
The portfolio connects external equity investments with the development of commercial platforms inside the Group. Scientific and industrial intelligence supports each route, from early technology selection to practical deployment.
Early investments in technology businesses that later reached public markets, including Insilico Medicine and BTQ Technologies.
Explore the companies →Investments in privately held frontier-technology companies, including OffWorld’s autonomous industrial robotics business.
Explore OffWorld →Capital and operating capability deployed to build Longevity Club, the Longevity Banking Card and GLIG.
Explore the products →Years of scientific and industrial profiling, extensive ecosystem databases and proprietary analytical methods provide the knowledge required for selective investment, technology acquisition and practical deployment.
Develop the taxonomies, analytical methods and readiness criteria that make a frontier domain comparable and intelligible.
Industry frameworks ↗Build extensive structured databases linking technologies, organisations, investors, institutions, infrastructure and expertise.
Ecosystem mapping ↗Translate those databases into big-data analytics, investment intelligence and dashboards for internal use and commercial applications.
Analytics and dashboards ↗Use that knowledge to select technology and IP, build projects and spinouts, and bring practical capabilities into real-world use.
Projects and priority domains ↗Insilico Medicine and BTQ illustrate DKG’s early investment in longevity, AI-enabled biotechnology and QuantumTech. Both subsequently became publicly traded, connecting the Group’s long-term technology focus with public-market milestones.

DKG, through Deep Knowledge Ventures, provided seed funding in 2014. This was the Group’s inaugural longevity investment. Insilico Medicine listed in Hong Kong on 30 December 2025, with the largest Hong Kong biotech IPO of that year by funds raised. The investment is a public-market milestone for DKG’s early focus on longevity and AI-enabled biotechnology.
Investors included Warburg Pincus, HongShan, Qiming Venture Partners, Hillhouse, Eight Roads, Lilly Asia Ventures, OrbiMed, Tencent, Temasek Holdings, Prosperity7 and WuXi AppTec.

Deep Knowledge Ventures invested in BTQ while it was privately held. BTQ later became publicly traded, providing a public-market reference for the Group’s early positioning in quantum technology and post-quantum cybersecurity.
DKG has invested in OffWorld, a privately held company developing AI-enabled autonomous robotic systems for mining and other demanding environments.
Its modular robots combine advanced controls with specialist excavation tools. The company’s technology programme spans terrestrial mining, industrial applications and the emerging lunar economy.
Explore OffWorld →The focus is on domains where scientific and engineering progress can create discontinuous value and where Deep Knowledge Group can bring more than capital.
Drug discovery, diagnostics, health intelligence, longevity and advanced care systems.
Quantum computing, sensing, security and enabling infrastructure.
Frontier engineering, space systems and technologies with terrestrial applications.
Platforms that convert complexity into measurable strategic advantage.
Alongside external equity investments, DKG finances the development of Longevity.Group and its commercial portfolio. These businesses connect consumer services, financial technology and enterprise intelligence.

A mobile and web membership platform combining concierge access, a health and wellbeing marketplace, member education and loyalty rewards.
Explore Longevity Club →
Financial and commerce infrastructure combining multi-currency accounts, a debit card, marketplace access and the Longevity Reward Points engine.
Explore the Card & rewards →
GLIG is a commercial intelligence platform for the Gulf’s HealthTech and longevity economy, connecting databases, analytics, market monitoring and business-development tools.
Explore GLIG →
The Group’s analytics and dashboard infrastructure supports its own investment process and is also productised for investors, corporations and institutions.
Evidence, ownership or licensing position, development stage and a clear route to practical use.
Technology assets and specialist capabilities that can strengthen or extend the Group’s own programmes.
Analytical frameworks, ecosystem mapping, benchmarking and forecasting for defined technology and capital decisions.
Integration, productization and implementation of frontier technologies in real operating environments.
Share the asset or capability, its evidence base, and the proposed acquisition, licensing or co-development route.